Toronto Dominion Bank’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-199
| Closed | -$1K | – | 1471 |
|
|
2024
Q2 | $1K | Buy |
+199
| New | +$1.52K | ﹤0.01% | 1237 |
|
|
2023
Q4 | – | Sell |
-593
| Closed | -$5.92K | – | 1848 |
|
|
2023
Q3 | $5.92K | Buy |
+593
| New | +$6.58K | ﹤0.01% | 1322 |
|
|
2022
Q3 | – | Sell |
-408
| Closed | -$8K | – | 1743 |
|
|
2022
Q2 | $8K | Buy |
408
+112
| +38% | +$2.8K | ﹤0.01% | 1204 |
|
|
2022
Q1 | $11K | Sell |
296
-15
| -5% | -$539 | ﹤0.01% | 1272 |
|
|
2021
Q4 | $11K | Buy |
311
+175
| +129% | +$9.22K | ﹤0.01% | 1398 |
|
|
2021
Q3 | $10K | Buy |
136
+27
| +25% | +$1.92K | ﹤0.01% | 1281 |
|
|
2021
Q2 | $9K | Sell |
109
-19
| -15% | -$1.81K | ﹤0.01% | 1261 |
|
|
2021
Q1 | $15K | Sell |
128
-157
| -55% | -$17.4K | ﹤0.01% | 1286 |
|
|
2020
Q4 | $12K | Buy |
+285
| New | +$10.5K | ﹤0.01% | 1229 |
|
|
2020
Q3 | – | Sell |
-1
| Closed | – | – | 1363 |
|
|
2020
Q2 | $0 | Buy |
+1
| New | +$92 | ﹤0.01% | 1394 |
|
|
2020
Q1 | – | Sell |
-29
| Closed | -$3K | – | 1490 |
|
|
2019
Q4 | $3K | Hold |
29
| – | – | ﹤0.01% | 1265 |
|
|
2019
Q3 | $3K | Buy |
29
+28
| +2,800% | +$6.06K | ﹤0.01% | 1366 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1792 |
|
|
2019
Q1 | $0 | Buy |
+1
| New | +$388 | ﹤0.01% | 1770 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | -$1K | – | 1689 |
|
|
2018
Q3 | $1K | Buy |
4
+3
| +300% | +$550 | ﹤0.01% | 1350 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1583 |
|
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1434 |
|
|
2017
Q4 | $0 | Buy |
+1
| New | +$208 | ﹤0.01% | 1313 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1253 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1292 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1292 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1267 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1317 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | – | – | 1299 |
|
|
2015
Q4 | $0 | Buy |
+1
| New | +$628 | ﹤0.01% | 1109 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1118 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1152 |
|
Other funds holding CSCI
FDCDDQ
TWC
TRCT
TC
PCMC
DB
Toronto Dominion Bank's CSCI Position: Q3 2024 in Review
Toronto Dominion Bank sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2024, closing a stake of 199 shares — an estimated $1K sold.
Toronto Dominion Bank first reported a position in CSCI in Q4 2015 and held it in 19 quarters. The position peaked at $15K in Q1 2021. 9 funds tracked by Wall St. Rank hold CSCI as of Q3 2024.
- Toronto Dominion Bank reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Toronto Dominion Bank sold 199 COSCIENS Biopharma Inc. Common Stock shares in Q3 2024, an estimated $1K.
- Toronto Dominion Bank first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2015 and held it in 19 quarters.
- Toronto Dominion Bank's COSCIENS Biopharma Inc. Common Stock position peaked at $15K in Q1 2021.
- 9 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2024.
Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.